About Pigment epithelium-derived factor
Pigment epithelium-derived factor (SERPINF1) is a protein
from Homo sapiens identified by UniProt accession
P36955, 418 residues long.
MolForge cross-references it against 0 known binders and
480 disease associations.
Target properties
| Protein name | Pigment epithelium-derived factor |
| UniProt accession | P36955 |
| Gene | SERPINF1 |
| Organism | Homo sapiens |
| Length | 418 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (480)
Diseases linked to this target (Open Targets).
- osteogenesis imperfecta · score 0.68
- osteogenesis imperfecta type 3 · score 0.45
- blood protein measurement · score 0.39
- osteogenesis imperfecta type 4 · score 0.37
- body height · score 0.36
- neurodegenerative disease · score 0.33
- forced expiratory volume · score 0.32
- vital capacity · score 0.30
- Abnormality of the skeletal system · score 0.27
- lean body mass · score 0.26
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P36955-F1 | alphafold | PREDICTED | 90.10 | — |
Amino-acid sequence (418 residues)
MQALVLLLCI GALLGHSSCQ NPASPPEEGS PDPDSTGALV EEEDPFFKVP VNKLAAAVSN FGYDLYRVRS STSPTTNVLL SPLSVATALS ALSLGAEQRT ESIIHRALYY DLISSPDIHG TYKELLDTVT APQKNLKSAS RIVFEKKLRI KSSFVAPLEK SYGTRPRVLT GNPRLDLQEI NNWVQAQMKG KLARSTKEIP DEISILLLGV AHFKGQWVTK FDSRKTSLED FYLDEERTVR VPMMSDPKAV LRYGLDSDLS CKIAQLPLTG SMSIIFFLPL KVTQNLTLIE ESLTSEFIHD IDRELKTVQA VLTVPKLKLS YEGEVTKSLQ EMKLQSLFDS PDFSKITGKP IKLTQVEHRA GFEWNEDGAG TTPSPGLQPA HLTFPLDYHL NQPFIFVLRD TDTGALLFIG KILDPRGP
Explore Pigment epithelium-derived factor with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets